UBS Group’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,483
| Closed | -$34.8K | – | 9783 |
|
|
2022
Q4 | $34.8K | Sell |
3,483
-434
| -11% | -$4.34K | ﹤0.01% | 5927 |
|
|
2022
Q3 | $39K | Buy |
3,917
+1,722
| +78% | +$17.1K | ﹤0.01% | 5520 |
|
|
2022
Q2 | $22K | Sell |
2,195
-337
| -13% | -$3.38K | ﹤0.01% | 5753 |
|
|
2022
Q1 | $25K | Buy |
2,532
+2,141
| +548% | +$21.1K | ﹤0.01% | 6177 |
|
|
2021
Q4 | $4K | Sell |
391
-2,109
| -84% | -$21.6K | ﹤0.01% | 8464 |
|
|
2021
Q3 | $24K | Sell |
2,500
-1,299
| -34% | -$12.5K | ﹤0.01% | 5859 |
|
|
2021
Q2 | $37K | Sell |
3,799
-155
| -4% | -$1.51K | ﹤0.01% | 5655 |
|
|
2021
Q1 | $39K | Buy |
+3,954
| New | +$39K | ﹤0.01% | 5781 |
|